LZTFL1 inhibits kidney tumor cell growth by destabilizing AKT through ZNRF1-mediated ubiquitin proteosome pathway.

LZTFL1 inhibits kidney tumor cell growth by destabilizing AKT through ZNRF1-mediated ubiquitin proteosome pathway.
复制标题

DOI:
10.1038/s41388-023-02666-x
复制
发表时间:
2023-05
期刊:
影响因子:
8
通讯作者:
Luo, Jun-hang
Luo, Jun-hang
中科院分区:
医学1区
文献类型:
--
作者:
Lu, Jun;Fu, Liang-min;Cao, Yun;Fang, Yong;Cao, Jia-zheng;Pan, Yi-hui;Cen, Jun-jie;Liang, Yan-ping;Chen, Zhen-hua;Wei, Jin-huan;Huang, Yong;Mumin, Mukhtar Adan;Xu, Quan-hui;Wang, Ying-han;Zhu, Jiang-quan;Liang, Hui;Wang, Zhu;Deng, Qiong;Chen, Wei;Jin, Xiao-han;Liu, Zhi-ping;Luo, Jun-hang

文献摘要

参考文献

相似文献

LZTFL1是一种位于染色体3p21.3区域的肿瘤抑制因子,在包括肾癌在内的多种癌症类型中经常早期缺失。然而,其在肾肿瘤发生中的作用仍然未知。在此,我们基于对患者肿瘤数据的大量生物信息学分析,假设LZTFL1在透明细胞肾细胞癌(ccRCC)中具有肿瘤抑制功能及其作用机制,并通过在肾肿瘤细胞系和患者来源的异种移植(PDX)模型系统中进行功能获得和功能缺失研究对其进行了验证。我们的研究表明,LZTFL1通过ZNRF1介导的泛素蛋白酶体途径使AKT不稳定,并诱导细胞周期停滞在G1期,从而抑制肾肿瘤细胞增殖。在临床上,我们发现LZTFL1在ccRCC中经常缺失。LZTFL1的下调与ccRCC预后不良相关,可作为预后标志物。此外,我们通过慢病毒递送在PDX中过表达LZTFL1抑制了PDX的生长,这表明LZTFL1的重新表达可能是一种针对ccRCC的治疗策略。
LZTFL1 is a tumor suppressor located in chromosomal region 3p21.3 that is deleted frequently and early in various cancer types including the kidney cancer. However, its role in kidney tumorigenesis remains unknown. Here we hypothesized a tumor suppressive function of LZTFL1 in clear cell renal cell carcinoma (ccRCC) and its mechanism of action based on extensive bioinformatics analysis of patients’ tumor data and validated it using both gain- and loss-functional studies in kidney tumor cell lines and patient-derive xenograft (PDX) model systems. Our studies indicated that LZTFL1 inhibits kidney tumor cell proliferation by destabilizing AKT through ZNRF1-mediated ubiquitin proteosome pathway and inducing cell cycle arrest at G1. Clinically, we found that LZTFL1 is frequently deleted in ccRCC. Downregulation of LZTFL1 is associated with a poor ccRCC outcome and may be used as prognostic maker. Furthermore, we show that overexpression of LZTFL1 in PDX via lentiviral delivery suppressed PDX growth, suggesting that re-expression of LZTFL1 may be a therapeutic strategy against ccRCC.
DOI: 10.3322/caac.20006
发表时间: 2009-07-01
影响因子: 254.7
作者:
Jemal, Ahmedin;Siegel, Rebecca;Thun, Michael J.
通讯作者: Thun, Michael J.
DOI: 10.1006/geno.2000.6498
发表时间: 2001-04-01
期刊: GENOMICS
影响因子: 4.4
作者:
Kiss, H;Kedra, D;Dumanski, JP
通讯作者: Dumanski, JP
miR-106b-5p通过激活Wnt/β-catenin信号传导促进肾细胞癌侵袭性和干细胞样表型
DOI: 10.18632/oncotarget.15591
发表时间: 2017-03-28
期刊: Oncotarget
影响因子: --
作者:
Lu J;Wei JH;Feng ZH;Chen ZH;Wang YQ;Huang Y;Fang Y;Liang YP;Cen JJ;Pan YH;Liao B;Chen WF;Chen W;Luo JH
通讯作者: Luo JH
DOI: 10.1016/j.path.2015.09.003
发表时间: 2015-12-01
影响因子: --
作者:
Hirsch, Michelle S;Signoretti, Sabina;Dal Cin, Paola
通讯作者: Dal Cin, Paola
DOI: 10.1016/j.tcb.2018.07.002
发表时间: 2018-11
影响因子: 19
作者:
Goel S;DeCristo MJ;McAllister SS;Zhao JJ
通讯作者: Zhao JJ